Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a -33.449% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
(a) O=C(Nc1ccc(Cl)cc1)Nc1nnc(/C=C/c2ccccc2)s1
(b) CCN1CCN(c2ncc(C(=O)Nc3ccc(F)cc3F)c3ccccc23)CC1
(c) CCN(CC)CCCNC(=O)CSc1nc(-c2cccs2)cc(C(F)(F)F)n1
Answer: c. CCN(CC)CCCNC(=O)CSc1nc(-c2cccs2)cc(C(F)(F)F)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCN(CC)CCCNC(=O)CSc1nc(-c2cccs2)cc(C(F)(F)F)n1
CCN(CC)CCCNC(=O)CSc1nc(-c2cccs2)cc(C(F)(F)F)n1
N-[3-(diethylamino)propyl]-2-[4-thiophen-2-yl-6-(trifluoromethyl)pyrimidin-2-yl]sulfanylacetamide